Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
2
40%
Ph phase_1
1
20%
Ph not_applicable
2
40%

Phase Distribution

1

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Recruiting3
Completed2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 11 (20.0%)
Phase 22 (40.0%)
N/A2 (40.0%)

Trials by Status

completed240%
recruiting360%

Recent Activity

3 active trials
Showing 5 of 5
recruitingnot_applicable

Ayahuasca, Esketamine and Body Image Perception

NCT07317219
recruitingnot_applicable

Ayahuasca, Esketamine and Premenstrual Symptoms

NCT07317232
recruitingphase_2

Ayahuasca, Esketamine and PTSD

NCT07317206
completedphase_2

Ayahuasca and Esketamine for Major Depression

NCT07212946
completedphase_1

Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression

NCT02914769

Clinical Trials (5)

Showing 5 of 5 trials
NCT07317219Not Applicable

Ayahuasca, Esketamine and Body Image Perception

Recruiting
NCT07317232Not Applicable

Ayahuasca, Esketamine and Premenstrual Symptoms

Recruiting
NCT07317206Phase 2

Ayahuasca, Esketamine and PTSD

Recruiting
NCT07212946Phase 2

Ayahuasca and Esketamine for Major Depression

Completed
NCT02914769Phase 1

Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5